Type and Screen Validity: The 72-Hour Rule

Standard Validity Period

• The standard blood banking practice considers a type and screen valid for up to 3 calendar days (72 hours) from sample collection to the actual transfusion event, for patients without recent transfusion or pregnancy 1, 2

The Critical 3-Month Window

• If a patient received any transfusion within the past 3 months, the type and screen expires after only 72 hours 1, 2
• If a patient has been pregnant within the past 3 months, the same 72-hour validity applies 1, 2
• New antibodies can develop rapidly following antigenic exposure from transfusion or pregnancy, necessitating the shortened window 1

Why This Matters for Morbidity and Mortality

• The 72-hour rule in recently transfused/pregnant patients prevents delayed hemolytic transfusion reactions from newly formed antibodies not detected on the original screen 1
• The 72-hour rule also prevents ABO incompatibility events from outdated testing 1, 2
• Transfusion delays that could worsen patient outcomes if antibodies are discovered only at the time of urgent need can be prevented by following the 72-hour rule 3, 4

Practical Algorithm for Repeat Testing

• If patient had transfusion/pregnancy in past 3 months AND still needs blood, repeat type and screen is mandatory on Day 3 (72 hours later) 1, 2
• If no recent transfusion/pregnancy history, the original sample remains valid through day 3 1, 2
• Beyond Day 3, a new sample is required for any patient regardless of transfusion/pregnancy history 1, 2

Special Populations Requiring Vigilance

• Multitransfused patients have the highest alloimmunization rates and can develop new antibodies rapidly, making the 72-hour rule particularly important 3, 4
• Historical samples may supplement current testing but cannot replace the 72-hour validity requirement in recently transfused/pregnant patients 1, 2